The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index; 13 of the 20 sources its claims cite were checked for support.
Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial
Open accessAbstract
BACKGROUND: Incomplete reporting is a frequent waste in research. Our aim was to evaluate the impact of a writing aid tool (WAT) based on the CONSORT statement and its extension for non-pharmacologic treatments on the completeness of reporting of randomized controlled trials (RCTs). METHODS: We performed a 'split-manuscript' RCT with blinded outcome assessment. Participants were masters and doctoral students in public health. They were asked to write, over a 4-hour period, the methods section of a manuscript based on a real RCT protocol, with a different protocol provided to each participant. Methods sections were divided into six different domains: 'trial design', 'randomization', 'blinding', 'participants', 'interventions', and 'outcomes'. Participants had to draft all six domains with access to the WAT for a random three of six domains. The random sequence was computer-generated and concealed. For each domain, the WAT comprised reminders of the corresponding CONSORT item(s), bullet points detailing all the key elements to be reported, and examples of good reporting. The control intervention consisted of no reminders. The primary outcome was the mean global score for completeness of reporting (scale 0-10) for all domains written with or without the WAT. RESULTS: Forty-one participants wrote 41 different manuscripts of RCT methods sections, corresponding to 246 domains (six for each of the 41 protocols). All domains were analyzed. For the primary outcome, the mean (SD) global score for completeness of reporting was higher with than without use of the WAT: 7.1 (1.2) versus 5.0 (1.6), with a mean (95 % CI) difference 2.1 (1.5-2.7; P <0.01). Completeness of reporting was significantly higher with the WAT for all domains except for blinding and outcomes. CONCLUSION: Use of the WAT could improve the completeness of manuscripts reporting the results of RCTs. TRIAL REGISTRATION: Clinicaltrials.gov ( http://clinicaltrials.gov NCT02127567 , registration date first received April 29, 2014).
Overview
CoChat Summary
TL;DR
A split-manuscript RCT tested whether an online CONSORT-based writing aid tool improves completeness of reporting in randomized trial methods sections. Among 41 public health master’s/doctoral students writing 246 domains, use of the tool increased the mean global completeness score from 5.0 to 7.1 on a 0–10 scale.
Key findings
- The primary outcome, mean global completeness score, was higher with the writing aid tool than without: 7.1 (SD 1.2) vs 5.0 (SD 1.6), mean difference 2.1 (95% CI 1.5–2.7; P < 0.001).
- Completeness was significantly higher with the tool for trial design (mean difference 5.4, 95% CI 4.1–6.7), randomization (3.8, 95% CI 1.1–4.4), participants (2.2, 95% CI 0.8–3.6), and interventions (1.8, 95% CI 0.7–2.9), but not for blinding or outcomes.
- Completeness of reporting for pre-specified essential elements was also higher with the tool: mean difference 1.4 (95% CI 0.5–2.3; P = 0.002).
- In an ancillary comparison, sections written without the tool did not significantly differ from published reports (mean difference −0.48, 95% CI −1.07 to 0.11), whereas sections written with the tool scored higher than published reports (mean difference +1.73, 95% CI 1.10–2.37; P < 0.001).
Methods
- Design: a “split-manuscript” RCT with blinded outcome assessment; the unit of randomization was the methods-section domain, embedded within each participant’s manuscript.
- Sample and data: 41 master’s and doctoral students in public health wrote methods sections for 41 different real RCT protocols over a 4-hour period, producing 246 domains (six per participant); each participant had access to the writing aid tool for a random three of six domains.
- Analysis: the primary outcome was the mean global completeness score (0–10) for all domains written with or without the tool; data were analyzed with mixed models including a fixed intervention effect, random participant effect, and random participant-group effect, with domain-specific Student t-tests and sensitivity analyses on weighting.
Limitations
- The paper states that participants were master’s and doctoral students and the writing session lasted only 4 hours, which is not representative of typical authors or the typical context of writing an RCT report.
- The paper states that the tool covered only six methods-section domains using CONSORT 2010 and the non-pharmacologic treatment extension, not all CONSORT items and extensions; it also notes relatedness between the experimental intervention and the evaluation, and lack of a validated outcome measure for reporting quality.
- The text makes evident that the ancillary comparison was not blinded to journal or author names, and the authors caution that readability of sections was not evaluated, so more complete sections could be harder to read.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
4 Valid · 1 Not valid · 1 Not checked · 43 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“For example, the method of randomization was described in only 25 % of published RCTs [10, 15, 22]”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Background
What the sources say
- Disputedcites [10] Hopewell S, Dutton S, Yu LM, Chan AW, Altman DG. The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed. BMJ. 2010;340:c723. sourceExperimental — accuracy not yet measured
In Results (Table 2, page unavailable), the paper reports that the method of random sequence generation was described in 34% of the 616 trials surveyed, not 25%. The 25% figure refers to reporting of allocation concealment, which the Methods treats as a separate item. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [15] Clark L, Schmidt U, Tharmanathan P, Adamson J, Hewitt C, Torgerson D. Poor reporting quality of key Randomization and Allocation Concealment details is still prevalent among published RCTs in 2011: a review. J Eval Clin Pract. 2013;19:703–7. source
- Disputedcites [22] Hewitt C, Hahn S, Torgerson DJ, Watson J, Bland JM. Adequacy and reporting of allocation concealment: review of recent trials published in four general medical journals. BMJ. 2005;330:1057–8. sourceExperimental — accuracy not yet measured
The Methods and results section reports that the allocation-concealment method was unclear in 61 of 234 trials (26%). The Comments section likewise says that about a quarter failed to describe how allocation was concealed—not that only a quarter described the method of randomization. The paper distinguishes allocation concealment from the randomization process and does not report the claimed 25% figure for randomization methods. (LLM, conf=0.87)
Checked by a reasoning model — may be wrong.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“and more than 30 % of reports did not provide sufficient details to allow replication of the treatment evaluated in the trial in clinical practice [11, 23].”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Background
What the sources say
- Not checked — no full text of the sourcecites [11] Glasziou P, Meats E, Heneghan C, Shepperd S. What is missing from descriptions of treatment in trials and reviews? BMJ. 2008;336:1472–4. source
- Supportedcites [23] Hoffmann TC, Erueti C, Glasziou PP. Poor description of non-pharmacological interventions: analysis of consecutive sample of randomised trials. BMJ. 2013;347:f3755. source
The Discussion reports that 61% of the non-pharmacological interventions assessed were not described in sufficient detail in the published primary report to enable replication in practice. That exceeds the claim’s threshold of more than 30%. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In fact, most active strategies used to improve the quality of reporting are implemented by editors and consist of asking authors to submit the CONSORT checklist at the submission or acceptance stage [9, 20].”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Background
What the sources say
- Partly supportedcites [9] Hopewell S, Altman DG, Moher D, Schulz KF. Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal ‘Instructions to Authors’. Trials. 2008;9:20. sourceExperimental — accuracy not yet measured
The Results (Survey of journal editors; page unavailable) list requiring a completed CONSORT checklist with manuscript submission as one editorial or peer-review practice. They also list other practices and do not establish that checklist submission constitutes most active strategies or that it is requested at acceptance. The Results (Survey of journals’ published Instructions to Authors; page unavailable) say 17 journals required a checklist at submission. (LLM, conf=0.85)
- Partly supportedcites [20] Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:e4178. sourceExperimental — accuracy not yet measured
The Methods (Interventions; page not specified) and Discussion (Comparison with other studies; page not specified) describe editor-led policies that improved abstract reporting. They describe emailing authors to revise abstracts at the manuscript revision stage and, sometimes, assistant editors making changes near the end of the process—not asking authors to submit a CONSORT checklist at submission or acceptance. The paper also does not establish that most active strategies take that form. (LLM, conf=0.87)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and outcomes, –0.3 (–2.0 to 1.3), P = 0.43.”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Outcomes
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The completeness of reporting (score 0–10) was significantly higher with than without the writing aid tool for all domains except blinding and outcomes.”
- Also stated in: § Results · plain
“Completeness of reporting was significantly higher with the WAT for all domains except for blinding and outcomes.”
- Also stated in: § Discussion · plain
“Completeness of reporting was significantly improved for all six domains of the methods section except for blinding and outcomes.”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Outcomes
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Results · plain
14 more claims
Create a free account to see all 49 claims and every source verdict.
- It may state two separate claims as one. 12
- Probably not a substantial claim. 26
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The bullet-point structure is new to PRISMA 2020 and has been adopted to facilitate implementation of the guidance [60, 61].”
From The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“La estructura de vin ˜etas es nueva en PRISMA 2020 y se ha adoptado para facilitar la implantacio ´ n de la guı ´a 56,57 .”
From Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas (2021) · cites this paper as [56]
In the citing paper
“La estructura de vin ˜etas es nueva en PRISMA 2020 y se ha adoptado para facilitar la implantacio ´ n de la guı ´a 56,57 .”
From Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas (2021) · cites this paper as [56]
In the citing paper
“To facilitate implementation, we also developed an expanded version of the SPIRIT 2025 checklist and an accompanying explanation and elaboration document.”
From SPIRIT 2025 statement: updated guideline for protocols of randomised trials (2025) · cites this paper as [29]
In the citing paper
“The bullet-point structure is new to PRISMA 2020 and has been adopted to facilitate implementation of the guidance [60,61].”
From The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews (2021) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“| Randomization | 8.4 (2.4) | 4.6 (2.9) | 3.8 (1.1–4.4) | <0.01** |”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Outcomes
Reported 3.8 · recomputed 2.75
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Non-pharmacologic, non-surgical | 9 (58.5 %) |”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Participants
Reported 58.5 · recomputed 21.95122
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Methods > Statistical methods
“To evaluate the robustness of our results, we performed a sensitivity analysis with simulations of different possible weighting systems (Additional file 5).”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Outcomes
“On sensitivity analyses, the results were robust to the choice of the weight (Additional file 4).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| Pharmacologic | 24 (22.0 %) |”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Participants
Reported 22 · recomputed 58.536585
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Protocols
“Overall, 20 protocols reported an RCT evaluating pharmacologic treatments”
§ Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial > Results > Participants
“| Pharmacologic | 24 (22.0 %) |”
2 more findings
Create a free account to see every finding of this check.
Citations
Cites
Moher, D., Hopewell, S., Schulz, K. F., Montori, V., Gotzsche, P. C., Devereaux, P. J., Elbourne, D., Egger, M., & Altman, D. G. (2010) · BMJ · doi:10.1136/bmj.c869 · Cited by 8,883 · cited 6×
“Second, the CONSORT Statement and its extension are disseminated in two formats: (1) the CONSORT Statement (a checklist and flow diagram) and (2) the CONSORT “Explanation and Elaboration” document [3, 7].”
MethodInfluentialSelf-citationConsort 2010 statement: extension to cluster randomised trials
Campbell, M. K., Piaggio, G., Elbourne, D. R., Altman, D. G., & for the CONSORT Group (2012) · BMJ · doi:10.1136/bmj.e5661 · Cited by 3,510 · cited 1×
“cluster [4], non-inferiority [5]), data (e.”
Self-citationPiaggio, G., Elbourne, D. R., Pocock, S. J., Evans, S. J. W., Altman, D. G., & CONSORT Group, F. T. (2012) · JAMA · doi:10.1001/jama.2012.87802 · Cited by 2,428 · cited 1×
“cluster [4], non-inferiority [5]), data (e.”
Self-citationBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292 · cited 3×
“The content of the tool was based on the checklist and the Explanation and Elaboration document for CONSORT 2010 [3] and the checklists and the Explanation and Elaboration documents of the CONSORT extension for nonpharmacologic treatment [7].”
MethodSelf-citationAvoidable waste in the production and reporting of research evidence
Chalmers, I., & Glasziou, P. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60329-9 · Cited by 2,208
Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement
Ioannidis, J. P. A., Evans, S. J. W., Gøtzsche, P. C., O'Neill, R. T., Altman, D. G., Schulz, K., Moher, D., & for the CONSORT Group* (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-10-200411160-00009 · Cited by 1,593 · cited 1×
“harms [6]), and interventions (nonpharmacologic treatments [7]).”
Self-citationReducing waste from incomplete or unusable reports of biomedical research
Glasziou, P., Altman, D. G., Bossuyt, P., Boutron, I., Clarke, M., Julious, S., Michie, S., Moher, D., & Wager, E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62228-x · Cited by 1,319 · cited 1×
“Background Inadequate reporting is a frequent cause of waste in research [1, 2].”
BackgroundSelf-citationTurner, L., Shamseer, L., Altman, D. G., Schulz, K. F., & Moher, D. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-60 · Cited by 628
Self-citationWhat is missing from descriptions of treatment in trials and reviews?
Glasziou, P., Meats, E., Heneghan, C., & Shepperd, S. (2008) · BMJ · doi:10.1136/bmj.39590.732037.47 · Cited by 614
Avoidable Waste in the Production and Reporting of Research Evidence
Chalmers, I., & Glasziou, P. (2009) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181c3020d · Cited by 600 · cited 1×
“Background Inadequate reporting is a frequent cause of waste in research [1, 2].”
Background
Cited by
The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n71 · Cited by 108,283
Self-citationThe PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01626-4 · Cited by 13,874
Self-citationPage, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · BMJ · doi:10.1136/bmj.n160 · Cited by 13,262
Self-citationThe PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · International Journal of Surgery · doi:10.1016/j.ijsu.2021.105906 · Cited by 11,748
Self-citationThe PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003583 · Cited by 5,148
“They include educators introducing reporting guidelines into graduate curricula to promote good reporting habits of early career scientists [65]; journal editors and regulators endorsing use of reporting guidelines [18]; peer reviewers evaluating adherence to reporting guidelines [61, 66]; journals requiring authors t…”
BackgroundMethodSelf-citation
Metadata
- Authors
- Barnes, C., Boutron, I., Giraudeau, B., Porcher, R., Altman, D. G., & Ravaud, P.
- Affiliations
- Inserm (FR)
- Université de Tours (FR)
- University of Oxford (GB)
- Corresponding author
- Boutron, Isabelle
- Venue
- BMC Medicine
- Published
- 2015-09-15
- Volume
- 13
- Issue
- 1
- Pages
- 221-221
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC4570037
- OpenAlex
- W1913246108
- Cited by
- 135
- References
- 31
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 13 · 2023: 6 · 2022: 11 · 2021: 30 · 2020: 14 · 2019: 11 · 2018: 3 · 2017: 13 · 2016: 6 · 2015: 3
- FWCI
- 3.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- BMC Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- Oxford University Research Archive (ORA) (University of Oxford) (submittedVersion, cc-by)
- Funders
- Cancer Research UK (16895)
- National Institute for Health and Care Research (NF-SI-0513-10131)
- Medical Research Council (MR/J00488X/1)
- Topics
- Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
- Social Sciences › Library and Information Sciences › Academic Writing and Publishing
- Social Sciences › Library and Information Sciences › Academic Publishing and Open Access
- Keywords
- CONSORT statement, reporting completeness, trial reporting, methods section, non-pharmacological treatment, research training, public health students, reporting guidelines
- MeSH terms
- Adult, Female, Humans, Male, Periodicals as Topic, Publishing, Research Design, Software, Randomized Controlled Trials as Topic, Medical Writing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-12, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-12 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12916-015-0460-y
- The paper
- Barnes, C., Boutron, I., Giraudeau, B., Porcher, R., Altman, D. G., & Ravaud, P. (2015). Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial. BMC Medicine. https://doi.org/10.1186/s12916-015-0460-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.


